Prophylactic treatment with progesterone decreases murine miscarriage by suppressing the immunostimulatory activity of macrophages
Molecular Human Reproduction · 2025
DOI: 10.1093/molehr/gaaf050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Human Reproduction, 2025. Verfasst von Yuki Kaito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Hauptthemen laut MEDLINE: Progesterone, Abortion, Spontaneous, Macrophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Miscarriage and preterm birth (PB) remain major challenges in obstetric care and are often associated with excessive inflammation at the feto–maternal interface. Although the role of progesterone (P4) in maintaining pregnancy is well known, its anti-inflammatory effects in immune-mediated pregnancy complications remain poorly understood. In this study, we investigated the impact of prophylactic P4 administration on miscarriage using a mouse model induced by α-galactosylceramide (αGC), a potent activator of invariant natural killer T (iNKT) cells. Prophylactic, but not therapeutic, P4 administration significantly reduced miscarriage rates. Flow cytometry analysis revealed that P4 suppressed the activity of iNKT cells and the production of inflammatory cytokines by these cells in the myometrium. Moreover, P4 reduced the immunostimulatory activity of antigen-presenting cells, particularly macrophages, by downregulating co-stimulatory molecules and interleukin (IL)-12 production. Immunohistochemistry and flow cytometry results demonstrated that the progesterone receptor (PR) was predominantly expressed on myometrial macrophages. Ex vivo experiments further confirmed that P4 directly modulates macrophage function, decreasing IL-12 and increasing IL-10 production. These findings suggest that prophylactic P4 administration mitigates immune activation at the feto–maternal interface by targeting macrophages, thereby suppressing iNKT cell-mediated inflammation and preventing miscarriage. This study highlights the importance of innate immune modulation in reproductive immunology and the potential of P4 as a prophylactic agent for preventing inflammation-associated miscarriage and PB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan.
- Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan.
ORCID-Profile: Yasuyuki Negishi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kaito, Y., Ino, H., Horii, Y., Watanabe, A., Nishigaki, M., Kubota, Y., Ichikawa, T., Negishi, Y., Kuwabara, Y., Morita, R., & Suzuki, S. (2025). Prophylactic treatment with progesterone decreases murine miscarriage by suppressing the immunostimulatory activity of macrophages. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaaf050
Vancouver
Kaito Y, Ino H, Horii Y, Watanabe A, Nishigaki M, Kubota Y, et al. Prophylactic treatment with progesterone decreases murine miscarriage by suppressing the immunostimulatory activity of macrophages. Molecular Human Reproduction. 2025. doi:10.1093/molehr/gaaf050
BibTeX
@article{Kaito2025,
author = {Kaito, Yuki and Ino, Hajime and Horii, Yumi and Watanabe, Asako and Nishigaki, Makoto and Kubota, Yumene and Ichikawa, Tomoko and Negishi, Yasuyuki and Kuwabara, Yoshimitsu and Morita, Rimpei and Suzuki, Shunji},
title = {Prophylactic treatment with progesterone decreases murine miscarriage by suppressing the immunostimulatory activity of macrophages},
journal = {Molecular Human Reproduction},
year = {2025},
doi = {10.1093/molehr/gaaf050}
}
EUVIMED